Preliminary Findings of European Commission After Pharmaceutical Sector Inquiry: Not so Preliminary?

December 12, 2008
The European Commission recently issued its preliminary report on its ongoing sector inquiry in the European pharmaceutical sector. The report reflects the Commission’s concern that a distortion of competition is occurring that can be traced primarily to the patent strategies implemented by originator companies. This update examines the key points in the report and the most significant implication to be drawn from it—that the pharmaceutical industry can expect to be the object of intensified antitrust scrutiny for months, perhaps years, to come.